The Institute of Nuclear Medicine at UCLH provides a high quality and comprehensive cancer imaging service utilising the latest imaging technologies.
We are able to detect and localise lesions using combined anatomical and functional imaging with SPECT-CT and PET-CT.
As well as tumour imaging with 18-FDG we routinely utilise other PET tracers including 68 Ga-DOTATATE ,18F-Choline and 18-Fluoride .
We provide a unique PET somatostatin receptor imaging service using an onsite 68Ga generator for labelling of octreotide ligands.
We have also performed the largest number of 18F-Choline PET-CT scans in the UK for patients with prostate carcinoma.
In April 2012 the UK's first PET-MRI scanner in the country was installed at the Cancer Imaging Centre, UCLH.
This is intended for use in clinical imaging in Cancer patients as well as research.
We accept referrals and working closely with clinical partners in nearby NHS trusts and also over a wider geographical area.